CCL5 and melanoma: Our data (Fig. S7C, middle and lower panels) revealed heightened expression of CD8+ T cell markers (CD8a and CD8b) and NK cell markers (NCR1 and NCR3) in melanoma patients with elevated levels of cGAS/CCL5/CXCL10.